Pulmonary embolism (PE) in patients with pulmonary sarcoidosis (PS)

O. Baranova, V. Perlei, A. Gichkin, V. Zolotnitskaya, A. Speranskaya (Saint-Petersburg, Russian Federation)

Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Session: Clinical management of interstitial lung diseases and vasculitis
Session type: Poster Discussion
Number: 4508
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Baranova, V. Perlei, A. Gichkin, V. Zolotnitskaya, A. Speranskaya (Saint-Petersburg, Russian Federation). Pulmonary embolism (PE) in patients with pulmonary sarcoidosis (PS). Eur Respir J 2014; 44: Suppl. 58, 4508

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Difficulties of diagnosis of pulmonary embolism (PE) in patients with lymphangioleiomyomatosis (LAM)
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013


Pulmonary embolism (PE) in amiodarone-induced pulmonary toxicity (AILT)
Source: International Congress 2016 – Orphan diseases II
Year: 2016


CPFE (combined pulmonary fibrosis and emphysema): A case series
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014


Bilateral chylothorax in a patient with chronic central vein thrombosis and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014


Pulmonary embolism in COPD patients
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013

Incidence of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) at six months of a Pulmonary Embolism (PE). OSIRIS Study
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017

Integration of the level of D-dimer (D-d) with Wells criteria to improve the prediction of pulmonary embolism (PE) before CT angiography of the lung (CTAL)
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Prevalence of relapses and chronic thromboembolic pulmonary hypertension (CTEPH) in patients with pulmonary embolism (PE)
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016


The management and follow-up of pulmonary embolism (PE) at a district general hospital: Are we missing CTEPH?
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013

From CTPA-proven pulmonary embolism to patients clinical characteristics
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013


Clinical assessment of pulmonary embolism rule-out criteria (PERC). Retrospective study (2006-2015)
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016

Pulmonary thromboembolism (PE) in patients with interstitial lung diseases (ILD)
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016


Stress-Doppler-Echocardiography for early detection of systemic sclerosis associated pulmonary arterial hypertension
Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases
Year: 2014


Late Breaking Abstract - Frequency Pulmonary embolism (PE) in patients with an acute Exacerbation of chronic obstructive Pulmonary disease (COPD). PEP prospective trial.
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019

Clinical significance of C reactive protein and MASTORA score in pulmonary embolism
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014


Evaluation of a novel clinic for management of Chronic Thromboembolic Pulmonary Disease (CTED) and associated Pulmonary Hypertension (CTEPH).
Source: International Congress 2017 – PAH and CTEPH
Year: 2017

30 years experience of plasmapheresis using in complex treatment of pulmonary sarcoidosis (PS)
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014


The incidence of chronic thromboembolic pulmonary hypertension in asympthomatic pulmonary embolism patients
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

Early screening for reperfusionand CTEPH after acute pulmonary embolism – Early screening for reperfusion and CTEPH after acutepulmonary embolism
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014

Long-term screening for pulmonary hypertension after pulmonary embolism
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014